FOLD

FOLD Other Income/Expenses (Net)

-$32.60MTTM · USD

Period ending:

FOLD FY Other Income/Expenses (Net)USD
FOLD FY Other Income/Expenses (Net)2003-12-31: -$168.00K2004-12-31: $0.002005-12-31: $247.27K2006-12-31: $514.36K2007-12-31: $4.64M2008-12-31: $4.60M2009-12-31: $783.00K2010-12-31: -$237.00K2011-12-31: $2.85M2012-12-31: $901.00K2013-12-31: $1.04M2014-12-31: -$1.34M2015-12-31: -$6.07M2016-12-31: -$21.89M2017-12-31: -$7.14M2018-12-31: -$23.61M2019-12-31: -$51.87M2020-12-31: -$27.26M2021-12-31: -$35.12M2022-12-31: -$29.92M2023-12-31: -$72.89M2024-12-31: -$53.63M2025-12-31: -$34.30M$4.64M-$72.89M
2003-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

FOLD other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 23 observations from Dec 31, 2003 to Dec 31, 2025.

Amicus Therapeutics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-34,300,000
-53,632,000
-72,890,000
-29,919,000
-35,120,000
-27,256,000
-51,873,000
-23,612,000
-7,136,000
-21,891,000
-6,073,000
-1,338,000
1,036,000
901,000
2,846,000
-237,000
783,000
4,601,000
4,638,000
514,363
247,269
0
-168,000

Compare other income/expenses (net)

All FOLD financial metrics · FOLD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.